Status:
COMPLETED
Comparison of NoaScope to the Conventional Stethoscope for Auscultation of Heart and Lung Sounds
Lead Sponsor:
Innova Smart Technologies (Pvt.) Ltd
Collaborating Sponsors:
Rehman Medical Institute - RMI
NOABIO LLC
Conditions:
Chest Pathology
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Assessing non-inferiority of a newly developed electronic stethoscope NoaScope in comparison with the conventional 3M Littmann stethoscope
Detailed Description
The enrolled population will include adults with a history of heart and lung complications. The enhanced sound quality of the electronic stethoscope and its non-inferiority to the traditional/conventi...
Eligibility Criteria
Inclusion
- Ages: 18 years or older (male and female)
- Hospital admitted or Out Patient Department
- Written consent provided
Exclusion
- Age \<18
- ICU admitted
- Written consent not provided
Key Trial Info
Start Date :
December 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2022
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05252130
Start Date
December 22 2021
End Date
February 10 2022
Last Update
April 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehman Medical Institute - RMI
Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000